navbar brand navbar brand
  • Course Catalog
  • Event Calendar
  • Contact Us

You are being redirected to another site.


Back to Post List
New Post
Title(*)
Description
  • Introduction
Click on the on the top progress bar to review the step.
MDS- ES Pump-based Therapies in Advanced Parkinson´s Disease
Course Format
Regional Online Course
Start Date
Thu, Aug 26, 2021
End Date
Sat, Aug 28, 2021
...
Program Description

The MDS- ES Pump-based Therapies in Advanced Parkinson´s Disease will provide knowledge about the neuropharmacological basis of treatment of advanced Parkinson´s disease (APD). It will also give a theoretical and practical education in the indication and the management of pump-based treatments for APD (including Levodopa-carbidopa intestinal gel, Levodopa-carbidopa entacapone intestinal gel and apomorphine)...

You cannot participate in this course

Registration for this course is now closed. Please email education@movementdisorders.org.

Faculty

Course Directors

David Devos, MD, PhD - University and Hospital Center of Lille, Lille, France
Anna Sauerbier, MD, PhD - University of Cologne, Cologne, Germany
Per Odin, MD, PhD - Lund University, Lund, Sweden

 

Faculty

Angelo Antonini, MD, PhD - University of Padua, Padua, Italy
Filip Bergquist, MD, PhD - Sahlgrenska University Hospital, Goteborg, Sweden
K. Ray Chaudhuri, MD, FRCP, DSc - King´s College, London, England
Cristian Falup-Pecurariu, MD, PhD - University of Transilvania Brasov Brasov, Romania
Tove Henriksen, MD - University Hospital of Bispebjerg Copenhagen, Denmark
Fabrizio Stocchi, MD, PhD - Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Pisana, Rome, Italy
Lars Timmermann, MD - University of Marburg, Marburg, Germany

Course Purpose

The primary purpose of this course is to present lectures on neuropharmacology, experimental basis of continuous dopaminergic stimulation (past, current and future treatments), history, patient selection, effects, side effects and practical management, as well as, interactive workshops on patient selection and choice of advanced therapy. An emphasis will also be case-based presentations.

The primary purpose of this program is to provide information on pump-based therapies in Advanced Parkinson's disease.

 

Registration Fees

Members: Free

Non-Members: $50

*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of session.

To view the course schedule please 'PROCEED TO COURSE'

Learning Objectives

Upon completion of this activity learners will be able to:

  1. Describe the neuropharmacological background for treatment of advanced Parkinson´s disease, including the relevance of continuous dopaminergic stimulation-based treatment
  2. Define the criteria and process for selecting the ideal patients for advanced Parkinson’s disease therapy through therapy comparison for a balanced outlook
  3. Compare the effects of pump treatment on motor and non-motor symptoms, quality of life, and the real-life based safety aspects of these therapies
  4. Demonstrate practical handling of pump-based therapies
  5. Plan a unit for pump-based therapies

Intended Audience

This activity is intended for Basic Science Researchers, Translational Researchers, Clinical Researchers, Clinical Nurse Specialists, Physio / Physical Therapists, and Occupational Therapists.

Method of Participation

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Faculty Disclosure

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

 

Faculty Disclosures

Angelo Antonini
Speaker
Nothing to Disclose

 

Filip Bergquist
Speaker
Grant: Neuroförbundet, R&D Västra Götaland

 

K. Ray Chaudhuri
Speaker
Consultant: AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Theravance, Scion, Britannia, Acadia, 4D
Speaker: AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis,Boehringer Ingelheim
Grant: Britannia Pharmaceuticals, AbbVie, UCB, GKC, Bial, EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), MRC, Wellcome Trust

David Devos
Planner, Speaker
Consultant: Abbvie, Alterity, Orkyn, Air Liquide, Apopharma, Lundbeck, Everpharma and Boston Scientific, Cure Parkinson Trust
Grant: PHRC grants, ANR, Coen, Horizon 2020
Equity Stake: InBrain Pharma

 

Cristian Falup-Pecurariu
Speaker
Nothing to Disclose

 

Tove Henriksen
Speaker
Researcher: AbbVie
Speaker: Britannia, EVER Pharma, AbbVie, Neuroderm

 

Per Odin
Planner, Speaker
Nothing to Disclose

 

Anna Sauerbier
Planner, Speaker
Nothing to Disclose

 

Fabrizio Stocchi
Speaker
Consultant: Chiesi Ltd., GlaxoSmithKline Plc., Impax Laboratories Inc., Lundbeck Ltd, Teva UK Limited, UCB Pharma Ltd, Merck & Co. Inc, Zambon Pharma, Novartis AG

 

Lars Timmermann
Speaker
Grant: Hoffnungsbaum e.V., Medtronic Inc., TEVA, Bayer, zur Rose Pharma, UCB
Speaker: TEVA, Lundbeck, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abott, GE Medical
Consultant: Medtronic Inc., Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma, AMN, GlaxoSmithKline, Abbott, Archimedes

Tamine Capato
Reviewer
Nothing to Disclose

Accreditation and Credit Designation

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Course Schedule

DAY 1 - Thursday, August 26, 2021

14:00 – 14:05 CEST Welcome and Course Introduction
David Devos, Anna Sauerbier, Per Odin
14:05 – 14:35 CEST

Neuropharmacology: from Levodopa related complications to continuous dopaminergic stimulation with examples of emerging therapies: the rationale

David Devos

14:35 – 15:05 CEST

Pump based therapies for Parkinson’s disease: history and development

Per Odin

15:05 – 15:35 CEST

Gastrointestinal dysfunction and rationale for therapeutic options in Parkinson’s disease

Cristian Falup-Pecurariu

15:35 – 15:50 CEST Break
15:50 – 16:20 CEST

What is best for me? Deep brain stimulation (DBS), Apomorphine or  Levodopa-carbidopa intestinal gel infusion therapy? Choice of advanced therapy

Angelo Antonini

16:20 – 16:50 CEST

Apomorphine infusion: Initiation of therapy and practical management

Anna Sauerbier

16:50 – 17:35CEST

Interactive Panel with Moderated Question & Answer

Faculty

17:35 – 17:45 CEST Concluding Remarks
David Devos, Anna Sauerbier, Per Odin

 

DAY 2 - Friday, August 27, 2021

14:00 – 14:05 CEST Welcome and Course Introduction
David Devos, Anna Sauerbier, Per Odin
14:05 – 14:35 CEST

Apomorphine infusion: Clinical effects and short/long term safety

Fabrizio Stocchi

14:35 – 15:05 CEST

Levodopa-carbidopa intestinal gel infusion: Initiation of therapy and practical management

Tove Henriksen

15:05 – 15:35 CEST

Levodopa-carbidopa intestinal gel infusion: Clinical effects and short/long term and safety

Per Odin

15:35 – 15:50 CEST Break
15:50 – 16:20 CEST

Other advanced therapies: Overview on DBS and focused ultrasound in advanced Parkinson´s disease

Lars Timmerman

16:20 – 17:05 CEST

Interactive session: Choice of advanced therapy -  practical real-life choices

K. Ray Chaudhuri

17:05– 17:50 CEST

Interactive Panel with Moderated Question & Answer

Faculty

17:50 – 18:00 CEST Concluding Remarks
David Devos, Anna Sauerbier, Per Odin

 

DAY 3 - Saturday, August 28, 2021

14:00 – 14:05 CESTWelcome and Course Introduction
David Devos, Anna Sauerbier, Per Odin
14:05 – 14:35 CEST

The role of objective and quantitative monitoring in advanced Parkinson´s disease

Filip Bergquist

14:35 – 15:05 CEST

Non-motor Symptoms: Relevance for advanced therapies     

K. Ray Chaudhuri

15:05 – 15:35 CEST

The challenges and new solutions to develop a treatment for Parkinson’s disease 

David Devos

15:35 – 15:50 CEST Break
15:50 – 16:50 CEST

Interactive session with case reports of different advanced therapies 

David Devos, Anna Sauerbier, Per Odin, Ray Chauhdhuri

16:50 – 17:35 CEST

Interactive Panel with Moderated Question & Answer

Faculty

17:35 – 17:45 CEST Concluding Remarks
David Devos, Anna Sauerbier, Per Odin

Hardware and Software Requirement

  1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
  2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
  3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
  4. Adobe Flash Player 12.0 (or higher).
  5. Adobe Reader to print certificate.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Supporter Information

The MDS-ES Pump-based Therapies in Advanced Parkinson´s Disease Course has received an unrestricted medical education grant from the following:

EVER Neuro Pharma GmbH

AbbVie, Inc.

 

Contact Us
MDS Education
education@movementdisorders.org
MDS Secretariat Liaison

Eric Johnson II

Interactive Sessions

The case presentations will be pre-recorded in advance and live streamed the date of the program with an interactive question answer session immediately following the recorded cases. Attendees are able to submit questions to expert panel in real time, and have the opportunity to answer multiple choice questions as the video cases are streamed online.

Lectures and associated resources available August 25, 2021.

Live/Interactive Components will commence on August 26-28, 2021 at 14:00 CEST.

 

Day 1: Thursday, August 26, 2021; 14:00 – 17:45 CEST

Day 2: Friday, August 27, 2021; 14:00 – 18:00 CEST

Day 3: Saturday, August 28, 2021; 14:00 – 17:15 CEST

Copyright © 1998-2025 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved.

Processing...
×